Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation

Detalles Bibliográficos
Autores principales: Lee, Jong-Mi, Ahn, Ari, Min, Eun Jeong, Lee, Sung-Eun, Kim, Myungshin, Kim, Yonggoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293273/
https://www.ncbi.nlm.nih.gov/pubmed/37365186
http://dx.doi.org/10.1038/s41408-023-00867-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293273/
https://www.ncbi.nlm.nih.gov/pubmed/37365186
http://dx.doi.org/10.1038/s41408-023-00867-x

Ejemplares similares